Yu Liang
- Molecular Biology top 10%
- Epidemiology top 5%
- Immunology top 10%
- Genetics top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Thomas M. KristieJodi L. VogelBernard RoizmanMaximilian DiehnAndrew W. BollenHua PengAarthi NarayananMark A. Israel
- Topics
- Herpesvirus Infections and Treatments (9 papers)Virus-based gene therapy research (5 papers)Cytomegalovirus and herpesvirus research (5 papers)
- Cited by
- GeneticsVirologyCancer Research
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yu Liang
37 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 865
- Epidemiology 604
- Immunology 358
- Genetics 353
- Radiology, Nuclear Medicine and Imaging 317
Countries citing papers authored by Yu Liang
This map shows the geographic impact of Yu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Liang more than expected).
Fields of papers citing papers by Yu Liang
This network shows the impact of papers produced by Yu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Liang. The network helps show where Yu Liang may publish in the future.
Co-authorship network of co-authors of Yu Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Yu Liang. A scholar is included among the top collaborators of Yu Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Liang. Yu Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 5 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 27 | |
| 6 | 16 | |
| 7 | 116 | |
| 8 | 30 | |
| 9 | Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity | 25 |
| 10 | 92 | |
| 11 | 237 | |
| 12 | 76 | |
| 13 | 345 | |
| 14 | 37 | |
| 15 | 33 | |
| 16 | 49 | |
| 17 | 20 | |
| 18 | 37 | |
| 19 | 22 | |
| 20 | 31 |
About Yu Liang
Yu Liang is a scholar working on Virology, Immunology and Allergy and Developmental Neuroscience, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (9 papers), Virus-based gene therapy research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Genetics (353 citations), Virology (155 citations) and Cancer Research (313 citations). Yu Liang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Thomas M. Kristie, Jodi L. Vogel, Bernard Roizman, Maximilian Diehn, Andrew W. Bollen, Hua Peng, Aarthi Narayanan, Mark A. Israel, Haidong Gu and Gail Mandel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.